Transplantační medicína

ESC/ESH recommend SPC therapy: ACEI/ARB + diuretic/CCB. Though ACEIs and ARBs are equally effective, ARBs are preferred in most patients.^1,2

ARBs have been proven to have cardioprotective and renoprotective effects, especially irbesartan.³ 

RAS blockers (esp. ARBs) + CCBs are preferred agents for hypertension management due to their multiple beneficial effects on the circulatory system⁴

ESC/ESH recommend SPC therapy: ACEI/ARB + diuretic/CCB. Though ACEIs and ARBs are equally effective, ARBs are preferred in most patients.^1,2

ARBs have been proven to have cardioprotective and renoprotective effects, especially irbesartan.³ 

RAS blockers (esp. ARBs) + CCBs are preferred agents for hypertension management due to their multiple beneficial effects on the circulatory system⁴

Datum: 18.-19.01.2024

Comprenderemos la evolución y manejo de la Enfermedad de Fabry. Explicaremos junto al Dr. Fernando Perretta cómo se realiza el seguimiento de los pacientes tratados y no tratados con terapias específicas y los diferentes estudios que se deben realizar para un correcto seguimiento.